Testing pulmonary vasoreactivity.
J Bras Pneumol
; 34(10): 838-44, 2008 Oct.
Article
en En, Pt
| MEDLINE
| ID: mdl-19009218
ABSTRACT
Pulmonary arterial hypertension is classified as idiopathic or secondary (associated with collagenoses, heart disease, portal hypertension, pulmonary thromboembolism, and pulmonary vascular diseases). Pulmonary vasoreactivity should be tested in order to define the best treatment option. Of the many drugs that have been used to test pulmonary vasoreactivity, inhaled nitric oxide is the best choice, due its specific pulmonary effect and very short half-life (5-10 s). The results of this test identify candidates for heart surgery among patients with congenital heart disease and candidates for the use of calcium antagonists among patients with other forms of pulmonary hypertension. Performing and interpreting the results of such tests are a great responsibility, since mistakes can lead to incorrect treatment decisions, resulting in the death of patients.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Arteria Pulmonar
/
Resistencia Vascular
/
Hipertensión Pulmonar
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
/
Pt
Revista:
J Bras Pneumol
Año:
2008
Tipo del documento:
Article
País de afiliación:
Brasil